Novo Nordisk Foundation's CEO warns antibiotic resistance will be world's second-biggest killer

If we fail to act, the world will risk antibiotic resistance becoming far worse, with fatal consequences exceeding our collective imaginations, says CEO of the Novo Nordisk Foundation Mads Krogsgaard Thomsen, though he highlights some efforts are being made to combat the threat.

Mads Krogsgaard Thomsen, CEO at the Novo Nordisk Foundation. | Photo: Gregers Tycho/ERH

While the third and fourth Covid-19 waves are rolling in over the world like tsunamis, CEO of the Novo Nordisk Foundation Mads Krogsgaard Thomsen warns of another red flag.

If action is not taken now, the world risks facing millions of deaths in the future due to antibiotic resistance. Deaths that could have been prevented.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs